뇌질환의 혁신, 뉴로벤티(NeuroVenti)

NEWS

Here's the news about NeuroVenti

Neuroventi selected as a start-up team through the ‘TIPS Program’, whi…

페이지 정보

조회 413회 작성일 19-08-05

본문

Neuroventi selected as a start-up team through the ‘TIPS Program’, which is synonymous with promising technology start-ups.

19-08-05


[yesTV News] Fostering 679 startup teams through TIPS program


Neuroventi Co., Ltd., founded by CEO Shin Chan-young to develop central nervous system treatment, was selected by TIPS and received investment from Synergy IB Investment Co., Ltd.

Neuroventi is the only bio-venture company in Korea that develops an autism treatment, and is attempting to develop a new autism drug for the first time in the world.

Lee Jong-hyeon, team leader of the Bio Investment Department of Synergy IB Investment Co., Ltd., a TIPS operating company, said that he decided to invest in Neuroventi Co., Ltd. because it gave great value in trying to develop an autism treatment for the first time in the world.


small business broadcasting